This is the current revision of this page, as edited by Ozzie10aaaa (talk | contribs) at 15:06, 16 March 2023 (Cleaned up using AutoEd). The present address (URL) is a permanent link to this version.
Revision as of 15:06, 16 March 2023 by Ozzie10aaaa (talk | contribs) (Cleaned up using AutoEd)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Chemical compound Pharmaceutical compoundClinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.170.829 |
Chemical and physical data | |
Formula | C20H16ClF2N5O2 |
Molar mass | 431.83 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Albaconazole (development code UR-9825) is an experimental triazole antifungal. It has potential broad-spectrum activity. The drug blocks a number of CYP450 liver enzymes.
It has also been studied as an antiprotozoal agent.
References
- "Albaconazole". Adis Insight. Springer Nature Switzerland AG.
- Guedes PM, Urbina JA, de Lana M, Afonso LC, Veloso VM, Tafuri WL, et al. (November 2004). "Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts". Antimicrobial Agents and Chemotherapy. 48 (11): 4286–92. doi:10.1128/AAC.48.11.4286-4292.2004. PMC 525424. PMID 15504854.
This antiinfective drug article is a stub. You can help Misplaced Pages by expanding it. |